COCHLEAR OUTER HAIR CELL REGENERATED BY ECTOPIC JOINT OVEREXPRESSION OF ATOH1 AND IKZF2 AND APPLICATION THEREOF

The present invention provides a cochlear outer hair cell (OHC) regenerated by ectopic joint overexpression of Atoh1 and Ikzf2 and an application thereof. Specifically, the present invention provides an active ingredient combination capable of being used for regenerating a cochlear OHC, and a use thereof. The active ingredient combination comprises an Ikzf2 protein and an Atoh1 protein; and after the active ingredient combination is administered to a subject suffering from hearing impairment related to cochlear OHC degeneration and/or injury, hearing impairment can be alleviated by regenerating an OHC-like cell. A new method is provided for clinical treatment of hearing impairment..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 07. März Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

LIU ZHIYONG [VerfasserIn]
SUN SUHONG [VerfasserIn]
LI SHUTING [VerfasserIn]
LUO ZHENGNAN [VerfasserIn]
REN MINHUI [VerfasserIn]
HE SHUNJI [VerfasserIn]
WANG GUANGQIN [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
bio
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-03-07, Last update posted on www.tib.eu: 2024-04-10, Last updated: 2024-04-19

Patentnummer:

US2024075098

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA001185683